Featured Research

from universities, journals, and other organizations

Common Component Of Fruits, Vegetables Kills Prostate Cancer Cells

Date:
August 22, 2007
Source:
University of Georgia
Summary:
A new study finds that pectin, a type of fiber found in fruits and vegetables and used in making jams and other foods, kills prostate cancer cells. The study found that exposing prostate cancer cells to pectin under laboratory conditions reduced the number of cells by up to 40 percent.

A new University of Georgia study finds that pectin, a type of fiber found in fruits and vegetables and used in making jams and other foods, kills prostate cancer cells.

The study, published in the August issue of the journal Glycobiology, found that exposing prostate cancer cells to pectin under laboratory conditions reduced the number of cells by up to 40 percent. UGA Cancer Center researcher Debra Mohnen and her colleagues at UGA, along with Vijay Kumar, chief of research and development at the VA Medical Center in Augusta, found that the cells literally self-destructed in a process known as apoptosis. Pectin even killed cells that aren’t sensitive to hormone therapy and therefore are difficult to treat with current medications.

“What this paper shows is that if you take human prostate cancer cells and add pectin, you can induce programmed cell death,” said Mohnen, a professor of biochemistry and molecular biology. “If you do the same with non-cancerous cells, cell death doesn’t occur.”

Mohnen’s study adds to the growing body of evidence on the health benefits of pectin, which has been shown to lower cholesterol and glucose levels in humans. Cancer studies using rats and cell cultures have found that pectin can reduce metastasis and prevent lung and colon tumors. Another study found that pectin induces apoptosis in colon cancer cells. Mohnen’s is the first to show that pectin induces apoptosis in prostate cancer cells and brings scientists closer to understanding what makes the common component of plants an effective cancer fighter.

In her lab at UGA’s Complex Carbohydrate Research Center, Mohnen and her team analyzed three different types of commercially available pectin and found large differences in anti-cancer activity. They found that treatment under mild base conditions decreased the anti-cancer properties of pectin while heat treatment significantly increased anti-cancer activity.

Pectin is one of nature’s most complex molecules and has the potential to bind to several sites on cells and to elicit several different cellular responses at the same time. Mohnen and her team are working to identify the smallest structure within pectin that can induce apoptosis with the ultimate goal of developing pectin-based pharmaceuticals or foods with enhanced health benefits.

Mohnen said that more evidence is needed to support the use of specific pectin supplements, but said that most Americans would do well to increase their intake of fruits and vegetables.

“Even though we hear constantly that we’re supposed to eat lots of fruits and vegetables, it wasn’t until we started working on these studies that it finally hit home how really important that was,” she said. “By simply increasing your intake of fruits of vegetables, you’re going to get a lot of pectin and you’re going to get all of the other beneficial phytochemicals at the same time.”

The research was funded by the Georgia Cancer Coalition-Georgia Department of Human Resources, the University of Georgia-Medical College of Georgia Joint Intramural Grants Program and the federal Department of Energy.


Story Source:

The above story is based on materials provided by University of Georgia. Note: Materials may be edited for content and length.


Cite This Page:

University of Georgia. "Common Component Of Fruits, Vegetables Kills Prostate Cancer Cells." ScienceDaily. ScienceDaily, 22 August 2007. <www.sciencedaily.com/releases/2007/08/070820120710.htm>.
University of Georgia. (2007, August 22). Common Component Of Fruits, Vegetables Kills Prostate Cancer Cells. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2007/08/070820120710.htm
University of Georgia. "Common Component Of Fruits, Vegetables Kills Prostate Cancer Cells." ScienceDaily. www.sciencedaily.com/releases/2007/08/070820120710.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins